Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion
David Basanta, Matthias Simon, Haralambos Hatzikirou, Andreas, Deutsch

TL;DR
This study uses evolutionary game theory to analyze how interactions between tumor cell phenotypes influence glioma progression, highlighting the role of glycolysis in promoting invasive behavior and suggesting potential therapeutic strategies.
Contribution
It introduces a model linking tumor phenotypes with evolutionary dynamics, revealing how glycolysis fosters invasion and proposing ways to inhibit this process.
Findings
Invasive phenotype emerges after glycolytic phenotype.
Glycolysis promotes tumor invasion.
Therapies increasing glycolysis cost may reduce invasiveness.
Abstract
Tumour progression has been described as a sequence of traits or phenotypes that cells have to acquire if the neoplasm is to become an invasive and malignant cancer. Although the genetic mutations that lead to these phenotypes are random, the process by which some of these mutations become successful and spread is influenced by the tumour microenvironment and the presence of other phenotypes. It is thus likely that some phenotypes that are essential in tumour progression will emerge in the tumour population only with the prior presence of other different phenotypes. In this paper we use evolutionary game theory to analyse the interactions between three different tumour cell phenotypes defined by autonomous growth, anaerobic glycolysis, and cancer cell invasion. The model allows to understand certain specific aspects of glioma progression such as the emergence of diffuse tumour cell…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMathematical Biology Tumor Growth · Microtubule and mitosis dynamics · Hippo pathway signaling and YAP/TAZ
